Question: Example(question='In an inactive state, a transcription factor subunit awaits an activation signal from the membrane phosphorylation cascade. Upon phosphorylation on the Ser residues in the transactivation domain, it dimerizes, shuttles into the nucleus, and serves in gene transcription. A missense mutation X in the transactivation domain is a recessive loss-of-function mutation. You observe that a heterozygous mutation Y in the dimerization domain acts as a dominant-negative mutation. Which of the following molecular phenotypes is most likely observed in the presence of mutation Y?', choice1='loss of protein dimerization and wild-type phenotype', choice2='protein aggregation and loss-of-function phenotype', choice3='protein degradation and loss-of-function of the wild-type allele', choice4='change of protein conformation and gain-of-function phenotype', correct_index=1)
Iteration: 0
Full Response:[Info(name='thinking', author='Chain-of-Thought Agent Oasb', content='Mutation Y in the dimerization domain forms nonfunctional heterodimers with wild-type subunits that misfold or aggregate, sequestering normal protein and preventing formation of active dimers, yielding a dominant-negative loss-of-function via aggregation.\n\nAnswer:B)', prompt=[{'role': 'system', 'content': "You are a helpful assistant.\n\nReply EXACTLY with the following JSON format.\n{'thinking': 'Your thinking.', 'answer': 'Your answer. If the question is asked for a multiple-choice result, Return ONLY the alphabet choice, i.e. `A)` or `B)` or `C)` or `D)` and no more explaination, or [ERROR] if you do not have the alphabet choice. If the question is asked for more than multiple-choice results, Return what the question asked and make sure the answer is complete.'}\nDO NOT MISS ANY REQUEST FIELDS and ensure that your response is a well-formed JSON object!\n\n"}, {'role': 'user', 'content': 'Related original question:\n\nExample(question=\'In an inactive state, a transcription factor subunit awaits an activation signal from the membrane phosphorylation cascade. Upon phosphorylation on the Ser residues in the transactivation domain, it dimerizes, shuttles into the nucleus, and serves in gene transcription. A missense mutation X in the transactivation domain is a recessive loss-of-function mutation. You observe that a heterozygous mutation Y in the dimerization domain acts as a dominant-negative mutation. Which of the following molecular phenotypes is most likely observed in the presence of mutation Y?\', choice1=\'loss of protein dimerization and wild-type phenotype\', choice2=\'protein aggregation and loss-of-function phenotype\', choice3=\'protein degradation and loss-of-function of the wild-type allele\', choice4=\'change of protein conformation and gain-of-function phenotype\', correct_index=1). \n\nRelated sub-task questions and answers:\n\n### Sub-task 1: Analyze the role of the transcription factor and how phosphorylation on Ser residues affects dimerization and gene transcription. \n\n ### thinking by Chain-of-Thought Agent tOZJ:\nThe question asks for the mechanistic role of the transcription factor and how serine phosphorylation impacts its dimerization and transcriptional activity. We explain how phosphorylation induces conformational changes, enabling dimer formation, nuclear import, and DNA binding to drive gene expression.\n\n### answer by Chain-of-Thought Agent tOZJ:\nThe transcription factor exists as an inactive monomer in the cytosol. Phosphorylation of serine residues in its transactivation domain induces a conformational change that exposes its dimerization interface and nuclear localization signals. This allows two monomers to dimerize, translocate into the nucleus, bind specific DNA response elements, recruit coactivators, and activate transcription of target genes.\n\n### Sub-task 2: Analyze the missense mutation X in the transactivation domain and its recessive loss-of-function effect. \n\n ### thinking #1 by Chain-of-Thought Agent ccn4:\nThe question asks for an analysis of how a missense mutation in the transactivation domain causes a recessive loss of function. I’ll explain its molecular impact on phosphorylation, transcriptional activation, and why it behaves recessively.\n\n### answer #1 by Chain-of-Thought Agent ccn4:\nMutation X alters one of the critical Ser residues in the transactivation domain, preventing its phosphorylation. As a result, the transcription factor can still dimerize and enter the nucleus, but it cannot recruit coactivators or the transcriptional machinery, abolishing its ability to drive gene expression. In heterozygotes, the wild-type allele provides sufficient functional protein, so no phenotype is seen; only homozygotes display loss of transcriptional activation.\n\n### Sub-task 3: Examine the heterozygous mutation Y in the dimerization domain and its dominant-negative effect. \n\n ### thinking by Final Decision Agent AU6H:\nThe question asks to explain how a heterozygous mutation in the dimerization domain exerts a dominant-negative effect. Based on the provided debate agents, the mutant protein still binds wild-type monomers but forms nonfunctional heterodimers that misfold or aggregate, sequestering the normal protein and preventing functional dimer formation, resulting in loss of activity despite one wild-type allele.\n\n### answer by Final Decision Agent AU6H:\nIn heterozygotes, mutation Y in the dimerization domain produces mutant subunits that still bind wild-type monomers to form heterodimers. These heterodimers are nonfunctional—they misfold or aggregate, sequestering the normal subunits and preventing assembly of active transcription-factor dimers. This dominant interference with the wild-type protein’s activity explains the dominant-negative loss-of-function effect.\n\nGiven the above, answer the following question: Sub-task 4: Based on the outputs from sub-tasks 1, 2, and 3, determine the most likely molecular phenotype when mutation Y is present.\n\nIf the question is too complicated or informaion is missing, you still need to give your best answer but add (1) an additional mark [TOO_HARD] in the next line of your final answer (2) information request or decomposison suggestion in the next line of the [TOO_HARD] mark, in the "answer" entry and justify why you think so in the "thinking" entry'}], sub_tasks=None, agents='CoT agent tOZJ, on the purpose of analyzing transcription factor function, thinking: The question asks for the mechanistic role of the transcription factor and how serine phosphorylation impacts its dimerization and transcriptional activity. We explain how phosphorylation induces conformational changes, enabling dimer formation, nuclear import, and DNA binding to drive gene expression.; answer: The transcription factor exists as an inactive monomer in the cytosol. Phosphorylation of serine residues in its transactivation domain induces a conformational change that exposes its dimerization interface and nuclear localization signals. This allows two monomers to dimerize, translocate into the nucleus, bind specific DNA response elements, recruit coactivators, and activate transcription of target genes.\nCoT agent ccn4, on the purpose of analyzing mutation X, thinking: The question asks for an analysis of how a missense mutation in the transactivation domain causes a recessive loss of function. I’ll explain its molecular impact on phosphorylation, transcriptional activation, and why it behaves recessively.; answer: Mutation X alters one of the critical Ser residues in the transactivation domain, preventing its phosphorylation. As a result, the transcription factor can still dimerize and enter the nucleus, but it cannot recruit coactivators or the transcriptional machinery, abolishing its ability to drive gene expression. In heterozygotes, the wild-type allele provides sufficient functional protein, so no phenotype is seen; only homozygotes display loss of transcriptional activation.\nCritic agent elJx, on the purpose of analyzing mutation X, feedback: The answer correctly explains that mutation X disrupts phosphorylation of a key Ser in the transactivation domain, leaving dimerization and nuclear import intact but preventing coactivator recruitment and transcriptional activation. It also accurately justifies the recessive phenotype by noting that a single wild-type allele suffices for normal function.; correct: True\nDebate agent H155, round 0, on the purpose of analyzing mutation Y, thinking: Mutation Y lies in the dimerization domain. In heterozygotes, mutant and wild-type monomers coexpress. The mutant subunit can still interact with wild-type via the dimer interface but disrupts the proper folding or stability of the dimer. As a result, mutant–wild-type dimers misfold or aggregate, preventing DNA binding and transcriptional activation by both subunits. This dominant-negative effect occurs even though one allele is normal, because the mutant protein poisons the function of the WT protein via heterodimer formation.; answer: When mutant Y is coexpressed with wild-type, mutant–WT heterodimers form but are misfolded or aggregate, sequestering and inactivating WT protein and causing a dominant-negative loss-of-function phenotype.\nDebate agent oENd, round 0, on the purpose of analyzing mutation Y, thinking: The dimerization-domain mutant protein can still bind the wild-type subunits, forming nonfunctional heterodimers that aggregate and sequester the normal protein, thus exerting a dominant-negative loss-of-function effect.; answer: B)\nDebate agent zL0c, round 0, on the purpose of analyzing mutation Y, thinking: A dominant-negative mutation in the dimerization domain typically allows mutant monomers to heterodimerize with wild-type monomers, but the resulting complexes are nonfunctional. These mixed dimers often misfold or aggregate, sequestering the wild-type protein and preventing it from forming functional homodimers, thus causing a dominant loss-of-function phenotype even in the presence of one normal allele.; answer: In heterozygotes carrying mutation Y, mutant and wild-type subunits form nonfunctional heterodimers that aggregate, sequestering the wild-type protein and causing a dominant-negative loss-of-function effect.\nDebate agent ttku, round 0, on the purpose of analyzing mutation Y, thinking: Mutation Y in the dimerization domain likely allows the mutant subunit to still dimerize with the wild-type, but the resulting heterodimers are nonfunctional and may aggregate, sequestering the wild-type protein and leading to a loss-of-function phenotype despite one normal allele, characteristic of dominant-negative effects.; answer: B)\nDebate agent H155, round 1, on the purpose of analyzing mutation Y, thinking: Mutation Y lies in the dimerization domain so that the mutant monomer can still interact with the wild‐type monomer. When coexpressed in heterozygotes, mutant–wild‐type heterodimers form but are misfolded or unstable. These nonfunctional complexes tend to aggregate or sequester the wild‐type protein, preventing formation of functional homodimers. As a result, even though one allele is normal, overall transcription factor activity is lost—a classic dominant‐negative effect.; answer: In heterozygotes, mutant and wild‐type subunits heterodimerize to form nonfunctional complexes that aggregate and sequester the normal protein, abolishing transcription factor activity.\nDebate agent oENd, round 1, on the purpose of analyzing mutation Y, thinking: Mutation Y is in the dimerization domain and when co-expressed with wild-type protein, the mutant subunits still bind the wild-type monomers but produce misfolded or nonfunctional heterodimers. These complexes can aggregate or sequester the normal protein, preventing formation of functional homodimers and blocking transcriptional activity even though one allele is wild-type—hallmarks of a dominant‐negative effect.; answer: In heterozygotes, mutant Y subunits dimerize with wild-type subunits to form nonfunctional heterodimers that aggregate or sequester the normal protein, thereby inhibiting overall transcription factor activity (dominant-negative effect).\nDebate agent zL0c, round 1, on the purpose of analyzing mutation Y, thinking: Mutation Y in the dimerization domain exerts a dominant-negative effect by forming mixed dimers with wild-type subunits that are nonfunctional. These heterodimers misfold or aggregate, sequestering the normal protein and preventing the formation of functional transcription factor complexes, leading to an overall loss of transcriptional activity despite one wild-type allele.; answer: In heterozygotes, mutant and wild-type monomers form nonfunctional heterodimers that misfold or aggregate, sequestering the wild-type protein and causing a dominant-negative loss-of-function effect.\nDebate agent ttku, round 1, on the purpose of analyzing mutation Y, thinking: Mutation Y in the dimerization domain produces a subunit that can still pair with wild-type monomers but disrupts the structure/function of the resulting dimers. These mutant–wild-type heterodimers misfold or aggregate, sequestering the normal subunits and preventing formation of active homodimers or functional heterodimers, thus inhibiting transcription even in the presence of one normal allele—a classic dominant-negative effect.; answer: In heterozygotes, mutant Y subunits form nonfunctional heterodimers with wild-type subunits that misfold or aggregate, sequestering the normal protein and blocking transcriptional activity (dominant-negative effect).\nDebate agent H155, round 2, on the purpose of analyzing mutation Y, thinking: Mutation Y is in the dimerization domain and, when co‐expressed with wild‐type protein in a heterozygote, still allows subunit interaction but disrupts dimer function. The mutant–wild‐type heterodimers misfold or aggregate, sequestering the normal monomers and preventing formation of functional dimers. This dominant interference with the wild‐type protein’s activity explains the dominant‐negative phenotype.; answer: In heterozygotes, mutant Y subunits form nonfunctional heterodimers with wild‐type subunits that misfold or aggregate, sequestering the normal protein and blocking formation of active homodimers, thereby abolishing transcriptional activity despite one normal allele.\nDebate agent oENd, round 2, on the purpose of analyzing mutation Y, thinking: Mutation Y is in the dimerization domain and when co-expressed with wild-type monomers it forms mixed dimers that are nonfunctional. These heterodimers misfold or aggregate, sequestering the normal protein and preventing formation of active homodimers or functional complexes, thereby blocking transcriptional activation even in the presence of one wild-type allele—hallmarks of a dominant-negative effect.; answer: In heterozygous cells, mutant subunits bearing mutation Y still bind wild-type monomers but produce misfolded or aggregated heterodimers that sequester the normal protein, preventing formation of functional transcription factor dimers and causing an overall loss-of-function despite one wild-type allele.\nDebate agent zL0c, round 2, on the purpose of analyzing mutation Y, thinking: Mutation Y is in the dimerization domain. The mutant protein can still pair with the wild-type monomer, but the resulting heterodimers are nonfunctional—they misfold or aggregate, sequestering the normal subunits. This prevents formation of active homodimers or functional heterodimers even though one allele is wild-type, thereby exerting a dominant-negative effect.; answer: Mutation Y produces subunits that dimerize with wild-type subunits to form nonfunctional heterodimers which misfold or aggregate, sequestering the normal protein and blocking assembly of active transcription-factor complexes, causing a dominant-negative loss of function.\nDebate agent ttku, round 2, on the purpose of analyzing mutation Y, thinking: Mutation Y lies in the dimerization domain and yields a subunit that can still pair with the wild-type monomer but disrupts the structure/function of the resulting dimers. These mixed dimers are nonfunctional, often misfold or aggregate, and sequester the normal protein, preventing formation of active homodimers and blocking transcriptional activity despite one wild-type allele—classical dominant-negative behavior.; answer: Mutation Y in the dimerization domain produces mutant subunits that still bind wild-type monomers but form nonfunctional heterodimers. These heterodimers misfold or aggregate, sequestering the normal protein and preventing formation of functional homodimers, leading to an overall loss of transcription factor activity even with one wild-type allele.\nFinal Decision agent, on the purpose of analyzing mutation Y, thinking: The question asks to explain how a heterozygous mutation in the dimerization domain exerts a dominant-negative effect. Based on the provided debate agents, the mutant protein still binds wild-type monomers but forms nonfunctional heterodimers that misfold or aggregate, sequestering the normal protein and preventing functional dimer formation, resulting in loss of activity despite one wild-type allele.; answer: In heterozygotes, mutation Y in the dimerization domain produces mutant subunits that still bind wild-type monomers to form heterodimers. These heterodimers are nonfunctional—they misfold or aggregate, sequestering the normal subunits and preventing assembly of active transcription-factor dimers. This dominant interference with the wild-type protein’s activity explains the dominant-negative loss-of-function effect.\nCoT agent a7BO, on the purpose of determining molecular phenotype, thinking: Mutation Y in the dimerization domain produces mutant subunits that heterodimerize with wild-type subunits, causing nonfunctional aggregates that sequester the normal protein and prevent active dimer formation, leading to a loss-of-function phenotype.; answer: B)\nCoT agent JR3u, on the purpose of determining molecular phenotype, thinking: Mutation Y in the dimerization domain forms nonfunctional heterodimers that misfold or aggregate, sequestering wild-type subunits and causing a dominant-negative loss-of-function phenotype consistent with protein aggregation.; answer: B)\nCoT agent Oasb, on the purpose of determining molecular phenotype, thinking: Mutation Y in the dimerization domain forms nonfunctional heterodimers with wild-type subunits that misfold or aggregate, sequestering normal protein and preventing formation of active dimers, yielding a dominant-negative loss-of-function via aggregation.; answer: B)', iteration_idx=-1)]